Press "Enter" to skip to content

Serum Institute of India to produce 1 bn dozes of Oxford-AstraZeneca COVID-19 vaccine

As the world awaits the reports of the initial trials of the COVID-19 vaccine developed by the esteemed Oxford University in collaboration with AstraZeneca, Serum Institute of India has entered a manufacturing partnership with the company wherein it the institute will manufacture and supply 1 billion dozes of the vaccine. 

Leave your comments

%d bloggers like this: